Home   Contact Palatin   Site Map  
 

Investor/Media Center

Investor Materials

    Management bios
     

For Institutional Investors and Media:

Carney Noensie
Burns McClellan
(212) 213-0006
cnoensie@burnsmc.com		  
   
          

Press Releases:

May-14-2013 Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
 
May-08-2013 Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
 
May-02-2013 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
 
Mar-19-2013 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
 
Mar-15-2013 PALATIN TECHNOLOGIES TO PRESENT AT THE 25TH ANNUAL ROTH CONFERENCE
 
Mar-04-2013 PALATIN TECHNOLOGIES, INC. TO PRESENT AT THE COWEN & COMPANY 33rd ANNUAL HEALTH CARE CONFERENCE
 
Mar-01-2013 Palatin Technologies Presents Positive Data for Bremelanotide in Female Sexual Dysfunction
 
Feb-14-2013 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013